{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:25:48Z","timestamp":1787725548602,"version":"build-2784847793"},"reference-count":334,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,13]],"date-time":"2027-02-13T00:00:00Z","timestamp":1802476800000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["T32 AA007565"],"award-info":[{"award-number":["T32 AA007565"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01-DA017763"],"award-info":[{"award-number":["R01-DA017763"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F31-DA060614"],"award-info":[{"award-number":["F31-DA060614"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01-DA052909"],"award-info":[{"award-number":["R01-DA052909"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01-DA061568"],"award-info":[{"award-number":["R01-DA061568"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pharmr.2026.100119","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:42:02Z","timestamp":1768981322000},"page":"100119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of polysubstance use in the development, maintenance, and treatment of stimulant use disorders"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2008-6994","authenticated-orcid":false,"given":"Mia I.","family":"Rough","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/14737167.2021.1916470","article-title":"Estimating the economic consequences of substance use and substance use disorders","volume":"21","author":"Manthey","year":"2021","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.pharmr.2026.100119_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jsat.2017.07.008","article-title":"Monetary conversion factors for economic evaluations of substance use disorders","volume":"81","author":"McCollister","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","article-title":"Polysubstance use in the U.S. opioid crisis","volume":"26","author":"Compton","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13011-021-00350-5","article-title":"Resurgent","volume":"16","author":"Fischer","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100119_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR, Morb Mortal Wkly Rep"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100119_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.15585\/mmwr.mm7432a1","article-title":"Drug overdose deaths involving stimulants-united states, January 2018 \u2013 June 2024","volume":"74","author":"Tanz","year":"2025","journal-title":"MMWR, Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0899-3289(10)80026-4","article-title":"Cocaine abuse treatment: a review of current strategies","volume":"3","author":"Rawson","year":"1991","journal-title":"J Subst Abuse"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib9","article-title":"Substance use disorder: a burning issue","volume":"6","author":"Mudasir","year":"2019","journal-title":"Glob J Addict Rehabil Med"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100119_bib10","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3390\/ph3072333","article-title":"The health effect of psychostimulants: a literature review","volume":"3","author":"Favrod-Coune","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.15288\/jsad.2018.79.799","article-title":"Polysubstance use by stimulant users: health outcomes over three years","volume":"79","author":"Timko","year":"2018","journal-title":"J Stud Alcohol Drugs"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/0091450919884739","article-title":"(Re)conceptualizing \u201cpolydrug use\u201d: capturing the complexity of combining substances","volume":"46","author":"Hakkarainen","year":"2019","journal-title":"Contemp Drug Probl"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100119_bib13","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/add.16290","article-title":"Why do we focus on the exception and not the rule? Examining the prevalence of mono- versus polysubstance use in the general population","volume":"118","author":"Bailey","year":"2023","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00952990.2023.2248360","article-title":"Are you thinking what I\u2019m thinking? Defining what we mean by \u2018polysubstance use.\u2019","volume":"50","author":"Bunting","year":"2024","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100119_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3928\/0048-5713-19880901-12","article-title":"Cocaine and alcoholism: distinct or part of a spectrum","volume":"18","author":"Miller","year":"1988","journal-title":"Psychiatr Ann"},{"key":"10.1016\/j.pharmr.2026.100119_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fnins.2020.00569","article-title":"One is not enough: understanding and modeling polysubstance use","volume":"14","author":"Crummy","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharmr.2026.100119_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107656","article-title":"Patterns of polysubstance use and simultaneous co-use in high risk young adults","volume":"205","author":"Bailey","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/inm.13144","article-title":"Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: a scoping review of the literature","volume":"32","author":"Leidl","year":"2023","journal-title":"Int J Ment Health Nurs"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14688","article-title":"Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction","volume":"1508","author":"Jones","year":"2022","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmr.2026.100119_bib20","article-title":"Characteristics and co-morbidities associated with hospital discharges for opioid and methamphetamine co-use, United States 2016\u20132019","volume":"10","author":"Shearer","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"issue":"suppl 2","key":"10.1016\/j.pharmr.2026.100119_bib21","first-page":"S53","article-title":"Pharmacology of drugs used as stimulants","volume":"61","author":"Docherty","year":"2021","journal-title":"J Clin Pharmacol"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100119_bib22","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1016\/j.bmc.2004.06.018","article-title":"Cocaine pharmacology and current pharmacotherapies for its abuse","volume":"12","author":"Carrera","year":"2004","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100119_bib23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","article-title":"A review of the clinical pharmacology of methamphetamine","volume":"104","author":"Cruickshank","year":"2009","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neubiorev.2005.04.016","article-title":"The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?","volume":"30","author":"Pierce","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"issue":"S 01","key":"10.1016\/j.pharmr.2026.100119_bib25","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1055\/s-0028-1124107","article-title":"Dopamine, reinforcement learning, and addiction","volume":"42","author":"Dayan","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharmr.2026.100119_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ejphar.2015.07.044","article-title":"Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms","volume":"764","author":"dela Pe\u00f1a","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100119_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1747-597X-2-33","article-title":"Mono- versus polydrug abuse patterns among publicly funded clients","volume":"2","author":"Kedia","year":"2007","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.pharmr.2026.100119_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2021.106950","article-title":"Trends and correlates of cocaine use among adults in the United States, 2006\u20132019","volume":"120","author":"Mustaquim","year":"2021","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(01)02847-5","article-title":"Ethanol administration potentiates cocaine-induced dopamine levels in the rat nucleus accumbens","volume":"915","author":"Lindholm","year":"2001","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0022-3565(24)37952-2","article-title":"Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine\/heroin combinations (Speedball) in rats","volume":"288","author":"Hemby","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib31","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/1098-2396(20001215)38:4<432::AID-SYN8>3.0.CO;2-Q","article-title":"Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor","volume":"38","author":"Gerasimov","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pharmr.2026.100119_bib32","series-title":"Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment","first-page":"21","article-title":"Role of dopamine in pleasure, reward and subjective responses to drugs","author":"Voruganti","year":"2007"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","article-title":"Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria","volume":"49","author":"Drevets","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0166-4328(02)00130-4","article-title":"Dopamine release in human ventral striatum and expectation of reward","volume":"136","author":"de la Fuente-Fern\u00e1ndez","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmr.2026.100119_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drugpo.2017.07.012","article-title":"\u2018I love having benzos after my coke shot\u2019: the use of psychotropic medication among cocaine users in downtown Montreal","volume":"49","author":"Motta-Ochoa","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.pharmr.2026.100119_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4899-1648-8_2","article-title":"Alcohol and cocaine. Clinical and pharmacological interactions","volume":"10","author":"Gorelick","year":"1992","journal-title":"Recent Dev Alcohol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archpsyc.1986.01800020013003","article-title":"Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations","volume":"43","author":"Gawin","year":"1986","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100119_bib38","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.bcp.2004.07.031","article-title":"A role for GABA mechanisms in the motivational effects of alcohol","volume":"68","author":"Koob","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"suppl 3","key":"10.1016\/j.pharmr.2026.100119_bib39","first-page":"36","article-title":"GABA systems, benzodiazepines, and substance dependence","volume":"64","author":"Malcolm","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100119_bib40","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.05-09-02365.1985","article-title":"Modulation of neurotransmitter action: control of the gamma-aminobutyric acid response through the benzodiazepine receptor","volume":"5","author":"Chan","year":"1985","journal-title":"J Neurosci"},{"issue":"suppl 3","key":"10.1016\/j.pharmr.2026.100119_bib41","first-page":"21","article-title":"The role of GABA in anxiety disorders","volume":"64","author":"Lydiard","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/hup.2468","article-title":"Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation","volume":"30","author":"Parrott","year":"2015","journal-title":"Hum Psychopharmacol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100119_bib43","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00213-019-05321-0","article-title":"Effects of cocaine base paste on anxiety-like behavior and immediate-early gene expression in nucleus accumbens and medial prefrontal cortex of female mice","volume":"236","author":"Berardino","year":"2019","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0022-3565(25)22944-5","article-title":"Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation","volume":"256","author":"Borowsky","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0006-8993(92)91176-F","article-title":"The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats","volume":"589","author":"Sarnyai","year":"1992","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","article-title":"Understanding polydrug use: review of heroin and cocaine co-use","volume":"98","author":"Leri","year":"2003","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib47","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0025-7125(05)70555-1","article-title":"Pharmacotherapy for opioid and cocaine abuse","volume":"81","author":"Warner","year":"1997","journal-title":"Med Clin North Am"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/10550887.2024.2331522","article-title":"Explaining the high mortality among opioid-cocaine co-users compared to opioid-only users. A systematic review","volume":"43","author":"van Amsterdam","year":"2024","journal-title":"J Addict Dis"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/00952999409109183","article-title":"Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance","volume":"20","author":"Stine","year":"1994","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.drugalcdep.2004.02.010","article-title":"Chronic opiate treatment enhances both cocaine-reinforced and cocaine-seeking behaviors following opiate withdrawal","volume":"75","author":"He","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.835816","article-title":"Dopamine supersensitivity: a novel hypothesis of opioid-induced neurobiological mechanisms underlying opioid-stimulant co-use and opioid relapse","volume":"13","author":"Strickland","year":"2022","journal-title":"Front Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13219","article-title":"Effects of chronic cocaine and ethanol self-administration on brain dopamine receptors in a rhesus monkey model of polysubstance abuse","volume":"27","author":"Say","year":"2022","journal-title":"Addict Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/syn.890140210","article-title":"Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers","volume":"14","author":"Volkow","year":"1993","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.revmed.2009.07.009","article-title":"Mechanisms of pharmacokinetic drug-drug interactions","volume":"31","author":"Lev\u00eaque","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.pharmr.2026.100119_bib55","doi-asserted-by":"crossref","unstructured":"Ahmed R. First-Pass Metabolism and Its Effect on Bioavailability, 2025. PsyArXiv. https:\/\/doi.org\/10.31234\/osf.io\/wzh5n_v1","DOI":"10.31234\/osf.io\/wzh5n_v1"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100119_bib56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jat\/19.6.459","article-title":"Pharmacokinetics and pharmacodynamics of cocaine","volume":"19","author":"Cone","year":"1995","journal-title":"J Anal Toxicol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jat\/bky007","article-title":"Bioavailability and pharmacokinetics of oral cocaine in humans","volume":"42","author":"Coe","year":"2018","journal-title":"J Anal Toxicol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib58","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2165\/00003088-199733050-00003","article-title":"Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users","volume":"33","author":"Quinn","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pharmr.2026.100119_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuropharm.2016.12.003","article-title":"The discriminative stimulus effects of iv nicotine in rhesus monkeys: pharmacokinetics and apparent pA2 analysis with dihydro-\u03b2-erythroidine","volume":"116","author":"Moerke","year":"2017","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib60","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/jpet.114.221945","article-title":"Chronic nicotine exposure attenuates methamphetamine-induced dopaminergic deficits","volume":"355","author":"Vieira-Brock","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib61","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0022-3565(25)39392-4","article-title":"Alcohol and cocaine interactions in humans","volume":"266","author":"Farr\u00e9","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib62","first-page":"647","article-title":"Effect of alcohol coadministration on the plasma and brain concentrations of cocaine in rats","volume":"25","author":"Hedaya","year":"1997","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/js980282p","article-title":"Cocaine and alcohol interactions in the rat: effect on cocaine pharmacokinetics and pharmacodynamics","volume":"88","author":"Pan","year":"1999","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100119_bib64","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0024-3205(92)90224-D","article-title":"Ethanol\/cocaine interaction: cocaine and cocaethylene plasma concentrations and their relationship to subjective and cardiovascular effects","volume":"51","author":"Perez-Reyes","year":"1992","journal-title":"Life Sci"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100119_bib65","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0024-3205(94)00747-0","article-title":"The order of drug administration: its effects on the interaction between cocaine and ethanol","volume":"55","author":"Perez-Reyes","year":"1994","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0009-9236(95)90041-1","article-title":"Methamphetamine and ethanol interactions in humans","volume":"57","author":"Mendelson","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib67","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1471-4159.1991.tb08205.x","article-title":"Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter","volume":"56","author":"Hearn","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2026.100119_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110952","article-title":"A comparison of the reinforcing strength of cocaethylene and cocaine in monkeys responding under progressive-ratio and concurrent choice schedules of reinforcement","volume":"251","author":"Allen","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1037\/1064-1297.8.1.117","article-title":"Comparison of the reinforcing and anxiogenic effects of intravenous cocaine and cocaethylene","volume":"8","author":"Raven","year":"2000","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib70","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3565(25)10557-0","article-title":"Cocaethylene: pharmacology, physiology and behavioral effects in humans","volume":"274","author":"McCance","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100119_bib71","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0024-3205(94)00638-5","article-title":"Discriminative effects of cocaethylene in rats trained to discriminate cocaine or ethanol","volume":"55","author":"Schechter","year":"1994","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1300\/J069v16n03_08","article-title":"Cocaethylene toxicity","volume":"16","author":"Andrews","year":"1997","journal-title":"J Addict Dis"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib73","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/acem.14584","article-title":"Cocaethylene cardiotoxicity in emergency department patients with acute drug overdose","volume":"30","author":"Shastry","year":"2023","journal-title":"Acad Emerg Med"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib74","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccc.2012.07.003","article-title":"Cocaine intoxication","volume":"28","author":"Zimmerman","year":"2012","journal-title":"Crit Care Clin"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib75","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1037\/a0022950","article-title":"Cocaethylene formation following ethanol and cocaine administration by different routes","volume":"19","author":"Herbst","year":"2011","journal-title":"Exp Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib76","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0091-3057(94)90338-7","article-title":"Marihuana smoking increases plasma cocaine levels and subjective reports of euphoria in male volunteers","volume":"48","author":"Lukas","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmr.2026.100119_bib77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drugalcdep.2018.07.025","article-title":"The importance of considering polysubstance use: lessons from cocaine research","volume":"192","author":"Liu","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109757","article-title":"Smoked cannabis reduces peak cocaine plasma levels and subjective effects in a controlled drug administration study of polysubstance use in men","volume":"243","author":"Murray","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100119_bib79","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0006-2952(01)00616-5","article-title":"Cannabinoid-induced alterations in brain disposition of drugs of abuse","volume":"61","author":"Reid","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100119_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110366","article-title":"\u03949-tetrahydrocannabinol induces blood-brain barrier disruption: involving the activation of CB1R and oxidative stress","volume":"270","author":"Zhang","year":"2025","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94212-6","article-title":"Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations","volume":"11","author":"Anderson","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib82","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/pharmaceutics12030265","article-title":"Cannabinoids, blood-brain barrier, and brain disposition","volume":"12","author":"Calapai","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib83","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005833","article-title":"Methamphetamine and cannabis abuse in adolescence: a quasi-experimental study on specific and long-term neurocognitive effects","volume":"5","author":"Cuzen","year":"2015","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib84","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.drugalcdep.2005.08.010","article-title":"The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence","volume":"81","author":"Williamson","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib85","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1521-0391.2009.00001.x","article-title":"Effect of cocaine use on buprenorphine pharmacokinetics in humans","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am J Addict"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1521-0391.2009.00009.x","article-title":"Effect of cocaine use on methadone pharmacokinetics in humans","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am J Addict"},{"key":"10.1016\/j.pharmr.2026.100119_bib87","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jsat.2014.10.010","article-title":"The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection","volume":"51","author":"Tetrault","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.pharmr.2026.100119_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116408","article-title":"A quantitative LC-MS\/MS method for investigation of polysubstance use involving heroin and cocaine","volume":"250","author":"Wei","year":"2024","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.pharmr.2026.100119_bib89","first-page":"6","article-title":"Pyrolytic characteristics, pharmacokinetics, and bioavailability of smoked heroin, cocaine, phencyclidine, and methamphetamine","volume":"115","author":"Cook","year":"1991","journal-title":"NIDA Res Monogr"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib90","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","article-title":"Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am J Addict"},{"key":"10.1016\/j.pharmr.2026.100119_bib91","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3389\/fphar.2018.01145","article-title":"Drug interactions with new synthetic opioids","volume":"9","author":"P\u00e9rez-Ma\u00f1\u00e1","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100119_bib92","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fgene.2012.00235","article-title":"MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?","volume":"3","author":"De La Torre","year":"2012","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib93","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/17425255.2022.2085552","article-title":"CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesia","volume":"18","author":"Ballester","year":"2022","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pharmr.2026.100119_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111272","article-title":"Sequencing hour-level temporal patterns of polysubstance use among persons who use cocaine, alcohol, and cannabis: a back-translational approach","volume":"258","author":"Fitzgerald","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100119_bib95","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/00952990802455451","article-title":"Predictors and comparisons of polydrug and non-polydrug cocaine use in club subcultures","volume":"34","author":"Kelly","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib96","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/alcalc\/agac006","article-title":"A scoping review of gender, sex and sexuality differences in polysubstance use in adolescents and adults","volume":"57","author":"Goodwin","year":"2022","journal-title":"Alcohol Alcohol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100119_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107336","article-title":"Polysubstance addiction patterns among 7,989 individuals with cocaine use disorder","volume":"26","author":"Stiltner","year":"2023","journal-title":"Iscience"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib98","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/dar.12263","article-title":"Polysubstance use, mental health and high-risk behaviours: results from the 2012 Global Drug Survey","volume":"34","author":"Morley","year":"2015","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib99","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/lgbt.2018.0149","article-title":"Latent classes of polysubstance use among adolescents in the United States: intersections of sexual identity with sex, age, and race\/ethnicity","volume":"6","author":"Coulter","year":"2019","journal-title":"LGBT Health"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0376-8716(95)01128-L","article-title":"Features of cocaine dependence with concurrent alcohol abuse","volume":"39","author":"Brady","year":"1995","journal-title":"Drug Alcohol Depend"},{"issue":"2\u20133","key":"10.1016\/j.pharmr.2026.100119_bib101","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drugalcdep.2009.08.002","article-title":"Patterns of illegal drug use among an adult alcohol dependent population: results from the National Survey on Drug Use and Health","volume":"106","author":"Hedden","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100119_bib102","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/JPER.19-0509","article-title":"Cocaine, polysubstance abuse, and oral health outcomes, NHANES 2009 to 2014","volume":"91","author":"Bahdila","year":"2020","journal-title":"J Periodontol"},{"key":"10.1016\/j.pharmr.2026.100119_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109273","article-title":"Cocaethylene, simultaneous alcohol and cocaine use, and liver fibrosis in people living with and without HIV","volume":"232","author":"Tamargo","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100119_bib104","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1360-0443.2003.00376.x","article-title":"Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990\u201398","volume":"98","author":"Coffin","year":"2003","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/08897077.2017.1389799","article-title":"Mortality risk in a sample of emergency department patients who use cocaine with alcohol and\/or cannabis","volume":"39","author":"Gilmore","year":"2018","journal-title":"Subst Abuse"},{"key":"10.1016\/j.pharmr.2026.100119_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109001","article-title":"Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups\u2013United States, 2004\u20132019","volume":"227","author":"Kariisa","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11524-018-00343-z","article-title":"Increased presence of fentanyl in cocaine-involved fatal overdoses: implications for prevention","volume":"96","author":"Nolan","year":"2019","journal-title":"J Urban Health"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100119_bib108","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1080\/10826080701209341","article-title":"Methamphetamine users entering treatment: characteristics of the methamphetamine treatment project sample","volume":"42","author":"Christian","year":"2007","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.pharmr.2026.100119_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108903","article-title":"Temporal trends in smoking and nicotine dependence in relation to co-occurring substance use in the United States, 2005\u20132016","volume":"226","author":"Wang","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13722-021-00267-1","article-title":"Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study","volume":"16","author":"Yen Li","year":"2021","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.pharmr.2026.100119_bib111","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2014.06.004","article-title":"The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users","volume":"142","author":"Bujarski","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112630","article-title":"National trends in co-use of opioids and methamphetamine among people who inject drugs, 2012\u20132018","volume":"271","author":"Reid","year":"2025","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib113","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/02791072.2013.785824","article-title":"Poly-drug and marijuana use among adults who primarily used methamphetamine","volume":"45","author":"Herbeck","year":"2013","journal-title":"J Psychoact Drugs"},{"key":"10.1016\/j.pharmr.2026.100119_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108162","article-title":"Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015\u20132018","volume":"214","author":"Shearer","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib115","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2105\/AJPH.2022.307212","article-title":"Methamphetamine-related mortality in the United States: co-involvement of heroin and fentanyl, 1999\u20132021","volume":"113","author":"Hoopsick","year":"2023","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib116","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.amepre.2024.10.012","article-title":"Sex differences in methamphetamine mortality in the United States: heroin and fentanyl coinvolvement, 1999\u20132021","volume":"68","author":"Sauda","year":"2025","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib117","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/00952990.2021.1981919","article-title":"Fentanyl and other opioid involvement in methamphetamine-related deaths","volume":"48","author":"Dai","year":"2022","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100119_bib118","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jamapsychiatry.2021.2588","article-title":"Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib119","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cardfail.2019.10.002","article-title":"Clinical characteristics and outcomes of patients with heart failure and methamphetamine abuse","volume":"26","author":"Thomas","year":"2020","journal-title":"J Card Fail"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0376-8716(97)00144-0","article-title":"An acute dose of nicotine enhances cue-induced cocaine craving","volume":"49","author":"Reid","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib121","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pbb.2013.03.008","article-title":"The influence of smoking cigarettes on the high and desire for cocaine among active cocaine users","volume":"106","author":"Brewer","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib122","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1037\/1064-1297.5.3.263","article-title":"Cocaine use can increase cigarette smoking: evidence from laboratory and naturalistic settings","volume":"5","author":"Roll","year":"1997","journal-title":"Exp Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib123","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.addbeh.2009.11.003","article-title":"Tobacco, cocaine, and heroin: craving and use during daily life","volume":"35","author":"Epstein","year":"2010","journal-title":"Addict Behav"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib124","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/00952990500479209","article-title":"Changes in tobacco smoking following treatment for cocaine dependence","volume":"32","author":"Patkar","year":"2006","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.pharmr.2026.100119_bib125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.drugalcdep.2013.09.019","article-title":"Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment","volume":"134","author":"Winhusen","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib126","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis","year":"2012","journal-title":"J Subst Abuse Treat"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100119_bib127","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100119_bib128","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax1532","article-title":"The treatment of cocaine use disorder","volume":"5","author":"Kampman","year":"2019","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1465-3362.2012.00423.x","article-title":"Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment","volume":"32","author":"Brensilver","year":"2013","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib130","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/FBP.0000000000000349","article-title":"Decreases in smoking during treatment for methamphetamine-use disorders: preliminary evidence","volume":"29","author":"McPherson","year":"2018","journal-title":"Behav Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib131","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","article-title":"Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence","volume":"96","author":"Shoptaw","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib132","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2018.04.023","article-title":"Varenicline treatment for methamphetamine dependence: a randomized, double-blind phase II clinical trial","volume":"189","author":"Briones","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib133","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3565(24)38905-0","article-title":"Bupropion is a nicotinic antagonist","volume":"295","author":"Slemmer","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib134","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/mol.106.025130","article-title":"Varenicline is a partial agonist at \u03b14\u03b22 and a full agonist at \u03b17 neuronal nicotinic receptors","volume":"70","author":"Mihalak","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(24)36982-4","article-title":"Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism","volume":"283","author":"Farr\u00e9","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib136","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0376-8716(03)00200-X","article-title":"The pharmacology of cocaethylene in humans following cocaine and ethanol administration","volume":"72","author":"Harris","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib137","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244943","article-title":"Acute behavioral and cardiac effects of cocaine and alcohol combinations in humans","volume":"111","author":"Higgins","year":"1993","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib138","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0091-3057(88)90399-1","article-title":"Ethanol and cocaine interactions in humans: cardiovascular consequences","volume":"31","author":"Foltin","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100119_bib139","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1360-0443.2002.00158.x","article-title":"Effects of concurrent use of alcohol and cocaine","volume":"97","author":"Pennings","year":"2002","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0376-8716(93)80001-U","article-title":"Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans","volume":"32","author":"Foltin","year":"1993","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib141","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02257405","article-title":"Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene","volume":"111","author":"McCance-Katz","year":"1993","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib142","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1081\/JA-200030693","article-title":"Gender effects following repeated administration of cocaine and alcohol in humans","volume":"40","author":"McCance-Katz","year":"2005","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.pharmr.2026.100119_bib143","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2015.08.005","article-title":"A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence","volume":"155","author":"Kampman","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib144","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/ajp.150.4.675b","article-title":"Disulfiram therapy in patients abusing cocaine and alcohol","volume":"150","author":"Higgins","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib145","first-page":"77","article-title":"Pharmacologic interventions for alcohol- and cocaine-abusing individuals: a pilot study of disulfiram vs naltrexone","volume":"2","author":"Carroll","year":"1993","journal-title":"Am J Addict"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib146","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1360-0443.1998.9357137.x","article-title":"Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram","volume":"93","author":"Carroll","year":"1998","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100119_bib147","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1046\/j.1360-0443.2000.95913355.x","article-title":"One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment","volume":"95","author":"Carroll","year":"2000","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib148","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/00023210-200721030-00003","article-title":"Pharmacotherapy of dual substance abuse and dependence","volume":"21","author":"Kenna","year":"2007","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib149","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archpsyc.61.3.264","article-title":"Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial","volume":"61","author":"Carroll","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100119_bib150","series-title":"Ethanol and Education: Alcohol as a Theme for Teaching Chemistry","first-page":"191","article-title":"The role of disulfiram in alcohol metabolism and the treatment of alcoholism","author":"Robinson","year":"2015"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib151","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopsych.2012.07.011","article-title":"Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine \u03b2-hydroxylase","volume":"73","author":"Kosten","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100119_bib152","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1038\/npp.2010.127","article-title":"Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine \u03b2-hydroxylase","volume":"35","author":"Schroeder","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib153","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/antibiotics12030524","article-title":"Disulfiram: mechanisms, applications, and challenges","volume":"12","author":"Lanz","year":"2023","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib154","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0740-5472(98)00039-7","article-title":"The effects of naltrexone on alcohol and cocaine use in dually addicted patients","volume":"16","author":"Oslin","year":"1999","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/10550490490480982","article-title":"Treatment of cocaine\u2013alcohol dependence with naltrexone and relapse prevention therapy","volume":"13","author":"Schmitz","year":"2004","journal-title":"Am J Addict"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib156","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/10550490903077929","article-title":"High-dose naltrexone therapy for cocaine-alcohol dependence","volume":"18","author":"Schmitz","year":"2009","journal-title":"Am J Addict"},{"key":"10.1016\/j.pharmr.2026.100119_bib157","series-title":"The Role of the \u03bc-Opioid Receptors in the Mechanism of Ethanol-Stimulated Mesolimbic Dopamine Release","author":"Job","year":"2009"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib158","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02244173","article-title":"Opiate antagonists reduce cocaine but not nicotine self-administration","volume":"104","author":"Corrigall","year":"1991","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib159","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(25)12759-6","article-title":"Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys","volume":"254","author":"Mello","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-011-2390-5","article-title":"Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans","volume":"219","author":"Kirkpatrick","year":"2012","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145707007778","article-title":"A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence","volume":"11","author":"Johnson","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100119_bib162","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2011.07.007","article-title":"Modafinil for the treatment of methamphetamine dependence","volume":"120","author":"Anderson","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib163","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugalcdep.2014.08.003","article-title":"Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature","volume":"143","author":"Courtney","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100119_bib164","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00213-017-4607-8","article-title":"Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder","volume":"234","author":"Roche","year":"2017","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100119_bib165","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1176\/appi.ajp.20220821","article-title":"Naltrexone and alcohol use","volume":"179","author":"Avery","year":"2022","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100119_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111018","article-title":"Bupropion for treatment of amphetamine-type stimulant use disorder: a systematic review and meta-analysis of placebo-controlled randomized clinical trials","volume":"253","author":"Bakouni","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib167","first-page":"56","article-title":"A preliminary, open-label study of naltrexone and bupropion combination therapy for treating binge drinking in human subjects","volume":"55","author":"Walter","year":"2020","journal-title":"Alcohol Alcohol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib168","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1590\/1516-4446-2020-1416","article-title":"Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study","volume":"43","author":"Meneses-Gaya Cd","year":"2021","journal-title":"Braz J Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100119_bib169","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/add.15417","article-title":"Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial","volume":"116","author":"Mongeau-P\u00e9russe","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.pharmr.2026.100119_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173376","article-title":"Cannabidiol effects on cognition in individuals with cocaine use disorder: exploratory results from a randomized controlled trial","volume":"216","author":"Rizkallah","year":"2022","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmr.2026.100119_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.666945","article-title":"Safety and preliminary efficacy of lorcaserin for cocaine use disorder: a phase I randomized clinical trial","volume":"12","author":"Johns","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100119_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109054","article-title":"Citalopram for treatment of cocaine use disorder: a Bayesian drop-the-loser randomized clinical trial","volume":"228","author":"Suchting","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100119_bib173","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drugalcdep.2009.11.023","article-title":"Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence","volume":"109","author":"Heinzerling","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100119_bib174","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/add.12608","article-title":"Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder","volume":"109","author":"Ling","year":"2014","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100119_bib175","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1176\/ajp.2006.163.11.1993","article-title":"Contingency management for the treatment of methamphetamine use disorders","volume":"163","author":"Roll","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib176","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/sj.npp.1301481","article-title":"Bupropion for the treatment of methamphetamine dependence","volume":"33","author":"Elkashef","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib177","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1017\/S1355617723000292","article-title":"Cannabis use may attenuate neurocognitive performance deficits resulting from methamphetamine use disorder","volume":"30","author":"Rogers","year":"2024","journal-title":"J Int Neuropsychol Soc"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib178","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.drugalcdep.2004.04.014","article-title":"Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure","volume":"76","author":"Gonzalez","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib179","article-title":"Cannabinoids and neuroinflammation: therapeutic implications","volume":"12","author":"Leonard","year":"2023","journal-title":"J Affect Disord Rep"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib180","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.0022-3042.2001.00716.x","article-title":"Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1","volume":"80","author":"Marsicano","year":"2002","journal-title":"J Neurochem"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100119_bib181","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/ph13110328","article-title":"Attenuation of oxidative stress by cannabinoids and cannabis extracts in differentiated neuronal cells","volume":"13","author":"Raja","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pharmr.2026.100119_bib182","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fpsyt.2019.00880","article-title":"Cognition and related neural findings on methamphetamine use disorder: insights and treatment implications from schizophrenia research","volume":"10","author":"Guerin","year":"2019","journal-title":"Front Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib183","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0022-3565(25)11084-7","article-title":"The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans","volume":"261","author":"Foltin","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib184","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3565(25)21159-4","article-title":"Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans","volume":"279","author":"Walsh","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1037\/1064-1297.3.3.261","article-title":"Interaction of buprenorphine with cocaine-morphine combinations","volume":"3","author":"Foltin","year":"1995","journal-title":"Exp Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib186","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0022-3565(25)20765-0","article-title":"Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans","volume":"278","author":"Foltin","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100119_bib187","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0006-3223(93)90258-F","article-title":"Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans","volume":"34","author":"Schottenfeld","year":"1993","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib188","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clpt.2003.09.004","article-title":"Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence","volume":"75","author":"Montoya","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib189","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts","volume":"95","author":"Petrakis","year":"2000","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100119_bib190","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/sj.npp.1300999","article-title":"Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers","volume":"31","author":"Haney","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib191","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1037\/1064-1297.11.2.123","article-title":"The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans","volume":"11","author":"Foltin","year":"2003","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib192","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13722-021-00266-2","article-title":"The impact of methamphetamine\/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review","volume":"16","author":"Frost","year":"2021","journal-title":"Addict Sci Clin Pract"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib193","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/add.14812","article-title":"Increases in methamphetamine use among heroin treatment admissions in the United States, 2008\u201317","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib194","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/15504263.2017.1325033","article-title":"Trends in opioid use disorder diagnoses and medication treatment among veterans with posttraumatic stress disorder","volume":"13","author":"Shiner","year":"2017","journal-title":"J Dual Diagn"},{"key":"10.1016\/j.pharmr.2026.100119_bib195","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.drugalcdep.2017.07.004","article-title":"Intravenous heroin use in Haiphong, Vietnam: need for comprehensive care including methamphetamine use-related interventions","volume":"179","author":"Michel","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib196","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF02287379","article-title":"Access to publicly funded methadone maintenance treatment in two western states","volume":"31","author":"Deck","year":"2004","journal-title":"J Behav Health Serv Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib197","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jsat.2011.10.022","article-title":"Factors associated with methadone treatment among injection drug users in Bangkok, Thailand","volume":"43","author":"Fairbairn","year":"2012","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100119_bib198","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1080\/10826084.2020.1765805","article-title":"Methamphetamine use and its correlates among individuals with opioid use disorder in a Midwestern U.S. city","volume":"55","author":"Daniulaityte","year":"2020","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.pharmr.2026.100119_bib199","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib200","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jsat.2010.05.001","article-title":"Methadone use among HIV-positive injection drug users in a Canadian setting","volume":"39","author":"Pettes","year":"2010","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib201","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0376-8716(00)00147-2","article-title":"Recent evolution in opiate dependence in France during generalisation of maintenance treatments","volume":"61","author":"Thirion","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib202","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000345229","article-title":"Increased somatic morbidity in the first year after leaving opioid maintenance treatment: results from a Norwegian cohort study","volume":"19","author":"Skeie","year":"2013","journal-title":"Eur Addict Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib203","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib204","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/09540121.2016.1259452","article-title":"Club drugs and alcohol abuse predicted dropout and poor adherence among methadone maintenance treatment patients in Guangzhou, China","volume":"29","author":"Liu","year":"2017","journal-title":"AIDS Care"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib205","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1360-0443.2009.02538.x","article-title":"Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users","volume":"104","author":"Banta-Green","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.pharmr.2026.100119_bib206","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2018.08.009","article-title":"Factors associated with methadone maintenance therapy discontinuation among people who inject drugs","volume":"94","author":"Lo","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib207","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10550880802324382","article-title":"One-year and cumulative retention as predictors of success in methadone maintenance treatment: a comparison of two clinics in the United States and Israel","volume":"27","author":"Peles","year":"2008","journal-title":"J Addict Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib208","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02287327","article-title":"Retention in publicly funded methadone maintenance treatment in two western states","volume":"32","author":"Deck","year":"2005","journal-title":"J Behav Health Serv Res"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100119_bib209","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.addbeh.2007.01.010","article-title":"Retention and illicit drug use among methadone patients in Israel: a gender comparison","volume":"32","author":"Schiff","year":"2007","journal-title":"Addict Behav"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib210","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsat.2014.04.006","article-title":"Emerging adult age status predicts poor buprenorphine treatment retention","volume":"47","author":"Schuman-Olivier","year":"2014","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib211","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1037\/adb0000090","article-title":"Predictors of patient retention in methadone maintenance treatment","volume":"29","author":"Proctor","year":"2015","journal-title":"Psychol Addict Behav"},{"key":"10.1016\/j.pharmr.2026.100119_bib212","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pnpbp.2018.01.008","article-title":"APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment","volume":"83","author":"Liu","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100119_bib213","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugpo.2018.02.020","article-title":"Factors associated with concurrent heroin use among patients on methadone maintenance treatment in Vietnam: a 24-month retrospective analysis of a nationally representative sample","volume":"55","author":"Hoang","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100119_bib214","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1360-0443.2010.03031.x","article-title":"Challenges to antagonist blockade during sustained-release naltrexone treatment","volume":"105","author":"Kun\u00f8e","year":"2010","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100119_bib215","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/14659891.2015.1118564","article-title":"Outcome predictors for patients receiving methadone maintenance treatment: findings from a retrospective multi-site study","volume":"21","author":"Proctor","year":"2016","journal-title":"J Subst Use"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib216","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12887-018-1137-4","article-title":"Opioid substitution treatment and heroin dependent adolescents: reductions in heroin use and treatment retention over twelve months","volume":"18","author":"Smyth","year":"2018","journal-title":"BMC Pediatr"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib217","doi-asserted-by":"crossref","first-page":"605","DOI":"10.15288\/jsad.2013.74.605","article-title":"Buprenorphine\/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START)","volume":"74","author":"Potter","year":"2013","journal-title":"J Stud Alcohol Drugs"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100119_bib218","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1465-3362.2009.00064.x","article-title":"Persistence of heroin use despite methadone treatment: poor coping self-efficacy predicts continued heroin use","volume":"28","author":"Senbanjo","year":"2009","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib219","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/08897077.2015.1065541","article-title":"Interim buprenorphine treatment in opiate dependence: a pilot effectiveness study","volume":"37","author":"Abrahamsson","year":"2016","journal-title":"Subst Abuse"},{"key":"10.1016\/j.pharmr.2026.100119_bib220","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnbeh.2019.00262","article-title":"Understanding addiction using animal models","volume":"13","author":"Kuhn","year":"2019","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib221","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tips.2025.01.003","article-title":"Animal models of cocaine use: importance of social context and co-use","volume":"46","author":"Allen","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmr.2026.100119_bib222","article-title":"Similarities in animal and human drug taking behavior","volume":"1090","author":"Griffiths","year":"1980","journal-title":"Adv Subst Abuse: Behav Biochem Res"},{"key":"10.1016\/j.pharmr.2026.100119_bib223","series-title":"Testing and Evaluation of Drugs of Abuse","first-page":"165","article-title":"Experimental evaluation of the reinforcing effects of drugs","author":"Woolverton","year":"1990"},{"key":"10.1016\/j.pharmr.2026.100119_bib224","series-title":"Biological Research on Addiction","first-page":"79","article-title":"Animal models of drug addiction: cocaine","author":"Martelle","year":"2013"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100119_bib225","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1360-0443.2007.02011.x","article-title":"Self-administration of drugs in animals and humans as a model and an investigative tool","volume":"102","author":"Panlilio","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.pharmr.2026.100119_bib226","first-page":"219","article-title":"Animal models of drug self-administration","volume":"2","author":"Johanson","year":"1981","journal-title":"Adv Subst Abuse"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib227","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0741-8329(90)90004-V","article-title":"Pharmacology of drug self-administration","volume":"7","author":"Koob","year":"1990","journal-title":"Alcohol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100119_bib228","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.addbeh.2005.02.007","article-title":"Subjective reactions to cocaine and marijuana are associated with abuse and dependence","volume":"30","author":"Grant","year":"2005","journal-title":"Addict Behav"},{"key":"10.1016\/j.pharmr.2026.100119_bib229","series-title":"Methods of behavior analysis in neuroscience","article-title":"Drug discrimination","author":"Young","year":"2009"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib230","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbr.2010.10.037","article-title":"Extinction of drug seeking","volume":"217","author":"Millan","year":"2011","journal-title":"Behav Brain Res"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100119_bib231","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmr.2026.100119_bib232","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.pbr.2015.07.012","article-title":"Animal models for addiction medicine: from vulnerable phenotypes to addicted individuals","volume":"224","author":"Nader","year":"2016","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pharmr.2026.100119_bib233","series-title":"Methods of Behavior Analysis in Neuroscience","article-title":"Conditioned place preference","author":"Prus","year":"2009"},{"issue":"3\u20134","key":"10.1016\/j.pharmr.2026.100119_bib234","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","article-title":"Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade","volume":"12","author":"Tzschentke","year":"2007","journal-title":"Addict Biol"},{"key":"10.1016\/j.pharmr.2026.100119_bib235","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.582147","article-title":"Drug-induced conditioned place preference and its practical use in substance use disorder research","volume":"14","author":"McKendrick","year":"2020","journal-title":"Front Behav Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib236","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/YCO.0000000000001010","article-title":"A case against purity: prioritizing translational polysubstance use research","volume":"38","author":"Gipson","year":"2025","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100119_bib237","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pbb.2014.06.013","article-title":"Nicotine enhances the expression of a sucrose or cocaine conditioned place preference in adult male rats","volume":"124","author":"Buffalari","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib238","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1037\/a0023373","article-title":"Discriminative and reinforcing stimulus effects of nicotine, cocaine, and cocaine + nicotine combinations in rhesus monkeys","volume":"19","author":"Mello","year":"2011","journal-title":"Exp Clin Psychopharmacol"},{"issue":"2\u20133","key":"10.1016\/j.pharmr.2026.100119_bib239","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02245147","article-title":"Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine","volume":"107","author":"Horger","year":"1992","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib240","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00213-002-1079-1","article-title":"Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats","volume":"162","author":"Bechtholt","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmr.2026.100119_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110960","article-title":"Nicotine modifies cocaine responding in a concurrent self-administration model","volume":"251","author":"Dawes","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib242","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-009-1637-x","article-title":"Self-administration of cocaine and nicotine mixtures by rhesus monkeys","volume":"207","author":"Freeman","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmr.2026.100119_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2024.100151","article-title":"Behavioral and neuronal extracellular vesicle biomarkers associated with nicotine\u2019s enhancement of the reinforcing strength of cocaine in female and male monkeys","volume":"11","author":"Allen","year":"2024","journal-title":"Addict Neurosci"},{"key":"10.1016\/j.pharmr.2026.100119_bib244","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.drugalcdep.2014.06.029","article-title":"Nicotine exposure beginning in adolescence enhances the acquisition of methamphetamine self-administration, but not methamphetamine-primed reinstatement in male rats","volume":"142","author":"Pipkin","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107927","article-title":"Effects of nicotine exposure on oral methamphetamine self-administration, extinction, and drug-primed reinstatement in adolescent male and female rats","volume":"209","author":"Harmony","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib246","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2019.01.005","article-title":"Effects of nicotine conditioning history on alcohol and methamphetamine self-administration in rats","volume":"179","author":"Randall","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100119_bib247","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/ntr\/ntab218","article-title":"Age- and sex-dependent nicotine pretreatment effects on the enhancement of methamphetamine self-administration in Sprague-Dawley rats","volume":"24","author":"Cardenas","year":"2022","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.pharmr.2026.100119_bib248","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugalcdep.2014.05.010","article-title":"IV prenatal nicotine exposure increases the reinforcing efficacy of methamphetamine in adult rat offspring","volume":"141","author":"Lacy","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib249","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2009.07.018","article-title":"Nicotine elicits methamphetamine-seeking in rats previously administered nicotine","volume":"106","author":"Neugebauer","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib250","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbr.2012.07.043","article-title":"Reinstatement of methamphetamine conditioned place preference in nicotine-sensitized rats","volume":"235","author":"Berry","year":"2012","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib251","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1124\/jpet.110.173773","article-title":"Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds","volume":"335","author":"Desai","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib252","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1124\/jpet.113.211235","article-title":"Methamphetamine-like discriminative-stimulus effects of nicotinic agonists","volume":"348","author":"Desai","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100119_bib253","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2007.08.020","article-title":"Nicotine and methamphetamine share discriminative stimulus effects","volume":"93","author":"Gatch","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100119_bib254","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv073","article-title":"Nicotine administration attenuates methamphetamine-induced novel object recognition deficits","volume":"18","author":"Vieira-Brock","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbr.2011.01.036","article-title":"Nicotine ameliorates impairment of working memory in methamphetamine-treated rats","volume":"220","author":"Mizoguchi","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmr.2026.100119_bib256","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.bbr.2018.06.016","article-title":"Nicotine and varenicline ameliorate changes in reward-based choice strategy and altered decision-making in methamphetamine-treated rats","volume":"359","author":"Mizoguchi","year":"2019","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100119_bib257","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/alcalc\/agg114","article-title":"Ethanol-reinforced behaviour predicts acquisition but not extinction of cocaine self-administration in the rat","volume":"38","author":"Mierzejewski","year":"2003","journal-title":"Alcohol Alcohol"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100119_bib258","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1007\/s00213-015-3937-7","article-title":"Sex differences in the long-lasting consequences of adolescent ethanol exposure for the rewarding effects of cocaine in mice","volume":"232","author":"Mateos-Garc\u00eda","year":"2015","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib259","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/npp.2016.209","article-title":"Prior exposure to alcohol has no effect on cocaine self-administration and relapse in rats: evidence from a rat model that does not support the gateway hypothesis","volume":"42","author":"Fredriksson","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2026.100119_bib260","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108707","article-title":"Effect of chronic binge-like ethanol consumption on subsequent cocaine reinforcement in rhesus monkeys","volume":"223","author":"Tryhus","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib261","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nn798","article-title":"Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration","volume":"5","author":"Morgan","year":"2002","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib262","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-023-06483-8","article-title":"Acquisition of cocaine reinforcement using fixed-ratio and concurrent choice schedules in socially housed female and male monkeys","volume":"241","author":"Johnson","year":"2024","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100119_bib263","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00213-025-06780-4","article-title":"Ethanol consumption prior to cocaine self-administration reduced vulnerability to cocaine reinforcement in socially subordinate female and male monkeys","volume":"242","author":"Allen","year":"2025","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib264","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0140525X00009766","article-title":"A reexamination of dominance rank and hierarchy in primates","volume":"4","author":"Kaplan","year":"1981","journal-title":"Behav Brain Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib265","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pnpbp.2003.09.031","article-title":"The modulation of cocaine-induced conditioned place preferences by alcohol: effects of cocaine dose","volume":"28","author":"Busse","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib266","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pbb.2006.08.012","article-title":"Alcohol consumption is preferred to water in rats pretreated with intravenous cocaine","volume":"85","author":"Knackstedt","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib267","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s002130050232","article-title":"Ethanol effects on self-administration of alfentanil, cocaine, and nomifensine in rhesus monkeys","volume":"130","author":"Aspen","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmr.2026.100119_bib268","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.drugalcdep.2015.05.016","article-title":"Effects of chronic binge-like ethanol consumption on cocaine self-administration in rhesus monkeys","volume":"153","author":"Czoty","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib269","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2016.11.002","article-title":"Effects of ethanol on cocaine self-administration in monkeys responding under a second-order schedule of reinforcement","volume":"170","author":"John","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100119_bib270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103608","article-title":"Ethanol self-administration prior to cocaine self-administration reduces sensitivity to cocaine reinforcement in socially housed monkeys","volume":"392","author":"Allen","year":"2025","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib271","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-3057(03)00158-8","article-title":"Effects of ethanol on cocaine discrimination in rats","volume":"75","author":"Gatch","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmr.2026.100119_bib272","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112965","article-title":"Ethanol self-administration reduced the efficacy of a behavioral intervention to decrease cocaine choice in socially housed male and female monkeys","volume":"277","author":"Rough","year":"2025","journal-title":"Drug Alcohol Depend"},{"issue":"2\u20133","key":"10.1016\/j.pharmr.2026.100119_bib273","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0091-3057(94)00378-V","article-title":"Cocaethylene produces discriminative stimulus properties in the rat: effect of cocaine and ethanol coadministration","volume":"51","author":"Schechter","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib274","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF02247473","article-title":"Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine","volume":"116","author":"Perez-Reyes","year":"1994","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib275","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11481-017-9764-3","article-title":"Methamphetamine-induced brain injury and alcohol drinking","volume":"13","author":"Blaker","year":"2018","journal-title":"J Neuroimmune Pharmacol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100119_bib276","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00702-011-0645-2","article-title":"Repeated co-administrations of alcohol- and methamphetamine-produced anxiogenic effect could be associated with the neurotoxicity in the dentate gyrus","volume":"118","author":"Chuang","year":"2011","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmr.2026.100119_bib277","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.drugalcdep.2017.03.026","article-title":"Methamphetamine-alcohol interactions in murine models of sequential and simultaneous oral drug-taking","volume":"177","author":"Fultz","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib278","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113771","article-title":"The effects of alcohol drinking on subsequent methamphetamine self-administration and relapse in adolescent female rats","volume":"422","author":"Kline","year":"2022","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib279","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/adb.12476","article-title":"Methamphetamine self-administration reduces alcohol consumption and preference in alcohol-preferring P rats","volume":"23","author":"Winkler","year":"2018","journal-title":"Addict Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib280","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.npp.1301109","article-title":"Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats","volume":"32","author":"Panlilio","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib281","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1037\/pha0000276","article-title":"Effects of adolescent \u03949-tetrahydrocannabinol exposure on the behavioral effects of cocaine in adult Sprague\u2013Dawley rats","volume":"27","author":"Friedman","year":"2019","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib282","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0269881116667706","article-title":"Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats","volume":"31","author":"Mahmud","year":"2017","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib283","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1124\/jpet.119.263707","article-title":"Cannabinoid modulation of food-cocaine choice in male rhesus monkeys","volume":"373","author":"John","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib284","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","article-title":"Effect of low doses of \u0394 9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats","volume":"175","author":"Parker","year":"2004","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib285","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/toxres\/tfaa021","article-title":"Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R\/AKT\/GSK-3\u03b2\/CREB signaling pathway in rats","volume":"9","author":"Yang","year":"2020","journal-title":"Toxicol Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib286","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/00952990.2022.2073450","article-title":"Cannabidiol attenuates methamphetamine-induced conditioned place preference in male rats and viability in PC12 cells through the Sigma1R\/AKT\/GSK3\u03b2\/CREB signaling pathway","volume":"48","author":"Liu","year":"2022","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.pharmr.2026.100119_bib287","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pnpbp.2017.08.022","article-title":"Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats","volume":"82","author":"Karimi-Haghighi","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100119_bib288","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111025","article-title":"Hippocampal D1-like dopamine receptor as a novel target for the effect of cannabidiol on extinction and reinstatement of methamphetamine-induced CPP","volume":"133","author":"Farrokhi","year":"2024","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib289","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/can.2022.0017","article-title":"Intra-accumbal D1- but not D2-like dopamine receptor antagonism reverses the inhibitory effects of cannabidiol on extinction and reinstatement of methamphetamine seeking behavior in rats","volume":"9","author":"Mirmohammadi","year":"2024","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.pharmr.2026.100119_bib290","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpsychires.2025.06.011","article-title":"Cannabidiol mechanism of action on modulating extinction and reinstatement of methamphetamine-seeking behavior: targeting D2-like dopamine receptors in the hippocampus","volume":"189","author":"Omidiani","year":"2025","journal-title":"J Psychiatr Res"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100119_bib291","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.3390\/molecules24142583","article-title":"Cannabidiol treatment might promote resilience to cocaine and methamphetamine use disorders: a review of possible mechanisms","volume":"24","author":"Calpe-L\u00f3pez","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2026.100119_bib292","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113158","article-title":"Cannabidiol efficiently suppressed the acquisition and expression of methamphetamine-induced conditioned place preference in the rat","volume":"404","author":"Anooshe","year":"2021","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmr.2026.100119_bib293","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111038","article-title":"The role of D1-like dopamine receptors within the ventral tegmental area in the cannabidiol\u2019s inhibitory effects on the methamphetamine-induced conditioned place preference in rats","volume":"216","author":"Ezzati","year":"2024","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharmr.2026.100119_bib294","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainresbull.2021.04.007","article-title":"Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region","volume":"172","author":"Hassanlou","year":"2021","journal-title":"Brain Res Bull"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100119_bib295","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1177\/0269881118799954","article-title":"Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats","volume":"32","author":"Hay","year":"2018","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pharmr.2026.100119_bib296","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainresbull.2022.11.003","article-title":"A 1 : 1 ratio of cannabidiol: tetrahydrocannabinol attenuates methamphetamine conditioned place preference in mice: a prospective study of antidopaminergic mechanism","volume":"192","author":"Nukitram","year":"2023","journal-title":"Brain Res Bull"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100119_bib297","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/sj.npp.1300454","article-title":"Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade","volume":"29","author":"Anggadiredja","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib298","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/026988110201600204","article-title":"Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251","volume":"16","author":"Vinklerov\u00e1","year":"2002","journal-title":"J Psychopharmacol"},{"issue":"1\u20133","key":"10.1016\/j.pharmr.2026.100119_bib299","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2010.02.005","article-title":"Effects of cannabinoid receptor antagonists on maintenance and reinstatement of methamphetamine self-administration in rhesus monkeys","volume":"633","author":"Schindler","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib300","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2010.12.013","article-title":"Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration","volume":"489","author":"Rodriguez","year":"2011","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100119_bib301","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098079","article-title":"\u03949-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity","volume":"9","author":"Castelli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100119_bib302","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157015","article-title":"Cannabidiol attenuates methamphetamine-induced oxidative neurotoxicity via regulating transient receptor potential vanilloid type 1","volume":"145","author":"Shen","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmr.2026.100119_bib303","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.972828","article-title":"Cannabidiol prevents methamphetamine-induced neurotoxicity by modulating dopamine receptor D1-mediated calcium-dependent phosphorylation of methyl-CpG-binding protein 2","volume":"13","author":"Shen","year":"2022","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib304","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0022-3565(25)10654-X","article-title":"A primate model of polydrug abuse: cocaine and heroin combinations","volume":"274","author":"Mello","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib305","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0022-3565(24)37510-X","article-title":"Discriminative stimulus effects of a cocaine\/heroin \u2018speedball\u2019 combination in rhesus monkeys","volume":"285","author":"Negus","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib306","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0091-3057(98)00021-5","article-title":"Effects of heroin\/cocaine combinations in rats trained to discriminate heroin or cocaine from saline","volume":"60","author":"Lamas","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib307","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(97)00062-9","article-title":"Differential effects of \u03bc-, \u03b4- and \u03ba-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats","volume":"324","author":"Suzuki","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib308","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s002130050415","article-title":"Self-administration of cocaine and heroin combinations by rhesus monkeys responding under a progressive-ratio schedule","volume":"133","author":"Rowlett","year":"1997","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100119_bib309","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1097\/00001756-199808030-00007","article-title":"Polydrug self-administration in rats: cocaine-heroin is more rewarding than cocaine-alone","volume":"9","author":"Ranaldi","year":"1998","journal-title":"NeuroReport"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib310","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0091-3057(98)00098-7","article-title":"The synergistic effects of combining cocaine and heroin (\u2018speedball\u2019) using a progressive-ratio schedule of drug reinforcement","volume":"61","author":"Duvauchelle","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib311","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1037\/1064-1297.5.2.113","article-title":"Smoked heroin and cocaine based (speedball) combinations in rhesus monkeys","volume":"5","author":"Mattox","year":"1997","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib312","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s002130100731","article-title":"Reinforcement by orally delivered methadone, cocaine, and methadone-cocaine combinations in rhesus monkeys: are the combinations better reinforcers?","volume":"156","author":"Wang","year":"2001","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib313","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0376-8716(00)00166-6","article-title":"The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys","volume":"62","author":"Winger","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100119_bib314","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/sj.npp.1300927","article-title":"Effects of high-dose methadone maintenance on cocaine place conditioning, cocaine self-administration, and mu-opioid receptor mRNA expression in the rat brain","volume":"31","author":"Leri","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmr.2026.100119_bib315","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.691700","article-title":"Impact of morphine dependence and withdrawal on the reinforcing effectiveness of fentanyl, cocaine, and methamphetamine in rats","volume":"12","author":"Seaman","year":"2021","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100119_bib316","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/sj.npp.1300435","article-title":"Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use","volume":"29","author":"Leri","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib317","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1901\/jeab.2011.95-75","article-title":"Effects of daily morphine administration and deprivation on choice and demand for remifentanil and cocaine in rhesus monkeys","volume":"95","author":"Wade-Galuska","year":"2011","journal-title":"J Exp Anal Behav"},{"key":"10.1016\/j.pharmr.2026.100119_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109773","article-title":"Oxycodone withdrawal is associated with increased cocaine self-administration and aberrant accumbens glutamate plasticity in rats","volume":"242","author":"Khatri","year":"2024","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100119_bib319","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1111\/ejn.16533","article-title":"Fentanyl self-administration is accelerated by methamphetamine co-use and results in worsened hypodopaminergia in male, but not female rats","volume":"60","author":"Dawes","year":"2024","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmr.2026.100119_bib320","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111098","article-title":"Effects of fentanyl and the adulterant levamisole on the rewarding and locomotor effects of methamphetamine in rats","volume":"256","author":"Paz-Ramos","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pharmr.2026.100119_bib321","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.814574","article-title":"Modeling stimulant and opioid co-use in rats provided concurrent access to methamphetamine and fentanyl","volume":"13","author":"Seaman","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100119_bib322","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2021.109110","article-title":"A drug-vs-food \u2018choice\u2019 self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disorders","volume":"354","author":"Townsend","year":"2021","journal-title":"J Neurosci Methods"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib323","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1471-4159.2009.05998.x","article-title":"Enhancing effects of morphine on methamphetamine-induced reinforcing behavior and its association with dopamine release and metabolism in mice","volume":"109","author":"Lan","year":"2009","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100119_bib324","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-3565(25)31445-X","article-title":"Enhancement of morphine analgesia and brain levels by methamphetamine in mice","volume":"207","author":"Sprague","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100119_bib325","doi-asserted-by":"crossref","DOI":"10.1002\/mpr.1912","article-title":"Test-retest reliability of a new assessment to detect detailed temporal patterns of polysubstance use","volume":"31","author":"Fitzgerald","year":"2022","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.pharmr.2026.100119_bib326","article-title":"Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: an observational study","volume":"146","author":"Ellis","year":"2023","journal-title":"J Subst Use Addict Treat"},{"key":"10.1016\/j.pharmr.2026.100119_bib327","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2025.100246","article-title":"The need to incorporate polysubstance use in neuropsychopharmacology research: biological lessons and new opportunities","volume":"18","author":"Joffe","year":"2026","journal-title":"Addict Neurosci"},{"key":"10.1016\/j.pharmr.2026.100119_bib328","series-title":"Drug Abuse: Origins & Interventions","first-page":"161","article-title":"Neurobiology of drug addiction","author":"Koob","year":"1999"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100119_bib329","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/156720208786413415","article-title":"Consequences of alcohol consumption on neurotransmitters -an overview","volume":"5","author":"Mukherjee","year":"2008","journal-title":"Curr Neurovasc Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100119_bib330","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0971-6866.132750","article-title":"Neurotransmitters in alcoholism: a review of neurobiological and genetic studies","volume":"20","author":"Banerjee","year":"2014","journal-title":"Indian J Hum Genet"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100119_bib331","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/j.1530-0277.1998.tb05897.x","article-title":"Individual differences in the biphasic effects of ethanol","volume":"22","author":"Holdstock","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pharmr.2026.100119_bib332","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-57369-0_1","article-title":"Constituents of Cannabis Sativa","volume":"1264","author":"Rock","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100119_bib333","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1523\/JNEUROSCI.2416-19.2020","article-title":"Vaporized cannabis extracts have reinforcing properties and support conditioned drug-seeking behavior in rats","volume":"40","author":"Freels","year":"2020","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmr.2026.100119_bib334","article-title":"Development of a preclinical inhalation model to test vaporized cannabis distillates","volume":"219","author":"Gorgani","year":"2025","journal-title":"J Vis Exp"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:21:30Z","timestamp":1778710890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":334,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0031699726000074"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100119","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of polysubstance use in the development, maintenance, and treatment of stimulant use disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100119"}}